{"id":"https://openalex.org/W2994431592","doi":null,"title":"Efficacy, immunogenicity and cost analysis of a systematic switch from originator infliximab to biosimilar CT-P13 of all patients with inflammatory arthritis from a single center.","display_name":"Efficacy, immunogenicity and cost analysis of a systematic switch from originator infliximab to biosimilar CT-P13 of all patients with inflammatory arthritis from a single center.","alternate_titles":[],"publication_year":2019,"publication_date":"2019-10-01","ids":{"openalex":"https://openalex.org/W2994431592","mag":"2994431592","pmid":"https://pubmed.ncbi.nlm.nih.gov/31754088"},"language":"en","primary_location":{"id":"pmid:31754088","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31754088","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta reumatologica portuguesa","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2994431592"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042420189","display_name":"Ana Valido","orcid":"https://orcid.org/0000-0001-5412-2642","observed_orcids":["https://orcid.org/0000-0001-5412-2642"]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]},{"id":"https://openalex.org/I4210149283","display_name":"Hospital de Santa Maria","ror":"https://ror.org/05bz1tw26","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210149283"]}],"countries":["PT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ana Valido","raw_affiliation_strings":["Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113982387","display_name":"Joana Silva-Dinis","orcid":"https://orcid.org/0000-0002-4829-1551","observed_orcids":["https://orcid.org/0000-0002-4829-1551"]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]},{"id":"https://openalex.org/I4210149283","display_name":"Hospital de Santa Maria","ror":"https://ror.org/05bz1tw26","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210149283"]}],"countries":["PT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joana Silva-Dinis","raw_affiliation_strings":["Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112455579","display_name":"Maria Jo\u00e3o Saavedra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]},{"id":"https://openalex.org/I4210149283","display_name":"Hospital de Santa Maria","ror":"https://ror.org/05bz1tw26","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210149283"]}],"countries":["PT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Jo\u00e3o Saavedra","raw_affiliation_strings":["Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062925052","display_name":"In\u00eas Iria","orcid":"https://orcid.org/0000-0002-3661-3760","observed_orcids":["https://orcid.org/0000-0002-3661-3760"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]}],"countries":["PT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"In\u00eas Iria","raw_affiliation_strings":["iMed - Research Institute for Medicines, Faculdade de Farm\u00e1cia da Universidade de Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"iMed - Research Institute for Medicines, Faculdade de Farm\u00e1cia da Universidade de Lisboa, Portugal","institution_ids":["https://openalex.org/I141596103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074484305","display_name":"Jo\u00e3o Gon\u00e7alves","orcid":"https://orcid.org/0000-0002-1245-3715","observed_orcids":["https://orcid.org/0000-0002-1245-3715"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]}],"countries":["PT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jo\u00e3o Gon\u00e7alves","raw_affiliation_strings":["iMed - Research Institute for Medicines, Faculdade de Farm\u00e1cia da Universidade de Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"iMed - Research Institute for Medicines, Faculdade de Farm\u00e1cia da Universidade de Lisboa, Portugal","institution_ids":["https://openalex.org/I141596103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030958309","display_name":"Jo\u00e3o Paulo Lopes","orcid":"https://orcid.org/0000-0002-6511-4063","observed_orcids":["https://orcid.org/0000-0002-6511-4063"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]}],"countries":["PT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jo\u00e3o Paulo Lopes","raw_affiliation_strings":["Faculdade de Farm\u00e1cia da Universidade de Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculdade de Farm\u00e1cia da Universidade de Lisboa, Portugal","institution_ids":["https://openalex.org/I141596103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043747371","display_name":"Jo\u00e3o Eurico Fonseca","orcid":"https://orcid.org/0000-0003-1432-3671","observed_orcids":["https://orcid.org/0000-0003-1432-3671"]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]},{"id":"https://openalex.org/I4210149283","display_name":"Hospital de Santa Maria","ror":"https://ror.org/05bz1tw26","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210149283"]}],"countries":["PT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jo\u00e3o Eurico Fonseca","raw_affiliation_strings":["Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servi\u00e7o de Reumatologia e Doen\u00e7as \u00d3sseas Metab\u00f3licas, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2385,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.76078017,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"44","issue":"4","first_page":"303","last_page":"311"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.8619999885559082},{"id":"https://openalex.org/keywords/ct-p13","display_name":"CT-P13","score":0.9290000200271606},{"id":"https://openalex.org/keywords/brand-name-drugs","display_name":"brand-name drugs","score":0.5299999713897705},{"id":"https://openalex.org/keywords/inflammatory-arthritis","display_name":"inflammatory arthritis","score":0.8629999756813049},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/spondyloarthritis","display_name":"spondyloarthritis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.996999979019165},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.9160000085830688},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5299999713897705},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.7120000123977661},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.6320000290870667},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.4959999918937683},{"id":"https://openalex.org/keywords/ankylosing-spondylitis","display_name":"ankylosing spondylitis","score":0.8209999799728394},{"id":"https://openalex.org/keywords/drug-cost-reduction","display_name":"drug cost reduction","score":0.32899999618530273},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.33000001311302185}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9430201053619385},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9369139075279236},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.845120370388031},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.8387004137039185},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6294116377830505},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6178767681121826},{"id":"https://openalex.org/C2777402515","wikidata":"https://www.wikidata.org/wiki/Q52849","display_name":"Ankylosing spondylitis","level":2,"score":0.5707827806472778},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.5031706690788269},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4377990961074829},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4238992929458618},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3455584943294525},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23234823346138},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.21744656562805176}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017046","descriptor_name":"Cost Savings","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D025241","descriptor_name":"Spondylarthritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D025241","descriptor_name":"Spondylarthritis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D057915","descriptor_name":"Drug Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:31754088","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31754088","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta reumatologica portuguesa","raw_type":"Journal Article"},{"id":"mag:2994431592","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31754088","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2909944289","https://openalex.org/W2808141733","https://openalex.org/W2613299853","https://openalex.org/W3206147259","https://openalex.org/W4383680013","https://openalex.org/W3044159591","https://openalex.org/W2789410014","https://openalex.org/W4250140140","https://openalex.org/W4413385750"],"abstract_inverted_index":{"Biosimilar":[0],"drugs":[1,175],"are":[2],"intended":[3],"to":[4,17,31,186,222,305,339,369],"be":[5],"as":[6,8,132],"effective":[7],"the":[9,50,169,173,217,223,288,315],"originator":[10,28],"product":[11],"but":[12],"with":[13,49,64,72,203,206,210,226,273,361],"a":[14,25,180,198,308,329],"lower":[15],"cost":[16,41,163],"healthcare":[18],"systems.":[19],"In":[20],"our":[21,177],"center":[22],"we":[23],"promoted":[24],"switch":[26,185,304,324],"from":[27,81,114,337],"infliximab":[29,33],"(IFXor)":[30],"biosimilar":[32],"(CT-P13).":[34],"We":[35,196],"analyzed":[36],"efficacy,":[37,344],"safety,":[38,345],"immunogenicity":[39,346],"and":[40,58,71,93,95,141,208,220,248,260,287,334,347,365],"savings":[42],"of":[43,52,112,121,172,182,200,253,284,312,317,328,331],"switching.":[44],"Eligible":[45],"patients":[46,192,202,237,255,267,300,336],"were":[47,130,150,358],"adults":[48],"diagnosis":[51],"rheumatoid":[53],"arthritis":[54,60],"(RA),":[55],"spondyloarthritis":[56],"(SpA)":[57],"psoriatic":[59],"(PsA)":[61],"on":[62,168],"therapy":[63,319],"IFXor":[65,338],"for":[66,91,103,193],"at":[67,176,271],"least":[68],"6":[69,144],"months":[70,233],"stable":[73,215],"disease":[74,363],"activity.":[75],"Efficacy":[76],"was":[77,107,165,188,214,231],"measured":[78],"considering":[79],"change":[80],"baseline":[82,115],"in":[83,87,96,116,123,190,282,298,314,320,325,350,355],"Disease":[84,99,105,212],"Activity":[85,100],"Score":[86,101],"28":[88],"joints":[89],"(DAS28)":[90],"RA":[92,207],"PsA":[94,335],"Ankylosing":[97],"Spondylitis":[98],"(ASDAS)":[102],"SpA.":[104],"worsening":[106],"considered":[108],"when":[109],"an":[110,119],"increase":[111,120],"1.2":[113],"DAS28":[117],"or":[118,157],"1.1":[122],"ASDAS":[124],"occurred.":[125],"Serum":[126],"IFX":[127,318,371],"levels":[128,149,259],"(sIFX)":[129],"dichotomized":[131,151],"therapeutic":[133],"(between":[134],"3-6":[135],"\u00b5g/mL),":[136,140],"low":[137,274],"(<":[138,159],"3":[139],"high":[142],"(>":[143,154],"\u00b5g/mL).":[145],"Anti-drug":[146],"antibody":[147],"(ADA)":[148],"into":[152],"detectable":[153,269,292],"10":[155,160],"ng/ml)":[156],"non-detectable":[158],"ng/ml).":[161],"A":[162,251],"analysis":[164],"done":[166],"based":[167],"purchasing":[170],"prices":[171],"2":[174,283],"center.":[178],"During":[179],"period":[181,219],"1":[183],"year":[184],"CT-P13":[187,306,340],"performed":[189],"60":[191],"non-medical":[194],"reasons.":[195],"had":[197,243,256,268],"total":[199,252],"36":[201],"SpA,":[204],"16":[205],"8":[209],"PsA.":[211],"activity":[213,364],"over":[216],"observation":[218],"similar":[221],"values":[224],"observed":[225,353],"IFXor.":[227],"Median":[228],"follow-up":[229],"time":[230],"15":[232],"during":[234,263],"which":[235],"5":[236,299],"stopped":[238],"CT-P13.":[239],"Forty":[240],"two":[241],"switchers":[242],"blood":[244,356],"samples":[245,357],"collected":[246],"before":[247],"after":[249,301],"switch.":[250,302],"27":[254],"unaltered":[257],"sIFX":[258,275],"ADA":[261,270,293],"status":[262],"follow":[264],"up.":[265],"Three":[266],"baseline,":[272],"levels.":[276,294],"After":[277],"switch,":[278],"ADAs":[279,295],"became":[280,296],"negative":[281],"those":[285],"patients,":[286],"other":[289],"patient":[290],"kept":[291],"positive":[297],"The":[303,323,352],"represented":[307],"26.4":[309],"%":[310],"reduction":[311],"costs":[313,349],"use":[316],"these":[321],"patients.":[322],"routine":[326],"care":[327],"group":[330],"RA,":[332],"SpA":[333],"did":[341,366],"not":[342,359,367],"affect":[343],"reduced":[348],"26.4%.":[351],"changes":[354],"associated":[360],"higher":[362],"lead":[368],"stopping":[370],"therapy.":[372]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2994431592","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2019-12-13T00:00:00"}
